Nasdaq Notifies Charming Medical Limited of Anticipated Delisting

Nasdaq notified Charming Medical Limited (MCTA) on October 29, 2026, of its intent to delist the company’s securities effective November 9, 2026. The action follows an SEC trading suspension and a Nasdaq trading halt that began November 26, 2025. The securities will remain halted while any appeal to a Listing Qualifications Hearings Panel is pending; after delisting, they may become eligible to trade over the counter.